Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass

European Journal of Cardio-thoracic Surgery

Volumn 11, Issue 4, 1997, Pages 626-632

  Tigchelaar, I ^a   Gallandat Huet, R C G ^a   Korsten, J ^a   Boonstra, P W ^a   Van Oeveren, W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cardiopulmonary bypass; Hemostasis; Plasma substitute

Indexed keywords

ADENOSINE DIPHOSPHATE; ALBUMIN; GELATIN; HETASTARCH; PLASMA SUBSTITUTE; RISTOCETIN; SEROTONIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; GELOPLASMA; HEMOSTASIS; HUMAN; PRIORITY JOURNAL;

ADULT; AGED; BLEEDING TIME; BLOOD LOSS, SURGICAL; CARDIOPULMONARY BYPASS; COLLOIDS; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; GELATIN; HEMOSTASIS; HETASTARCH; HUMANS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; PLATELET AGGREGATION; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 0030935289     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)01059-7     Document Type: Article

References (25)

1. Åberg M, Hedner U, Bergentz SE. Effect of dextran on Factor VIII (antihemophilic factor) and platelet function. Ann Surg 1977;189:243-247.
2. Boldt J, Zickmann B, Ballesteros BM, Stertmann F, Hempelmann G. Influence of five different priming solutions on platelet function in patients undergoing cardiac surgery. Anesth Analg 1992;74:219-225.
3. Boonstra PW, Gu YJ, Akkerman C, Haan J, Huyzen R, van Oeveren W. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:289-292.
4. Cardinal DC, Flowers RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980;3:135-158.
5. Diehl JT, Lancelot Lester J, Cosgrove DM. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Ann Thorac Surg 1982;34:674-679.
6. Hässig A, Stampfli K. In: Lundsgaard-Hansen P, Hässig A, Nitschmann H. Karger, editors. Modified gelatins as plasma substitutes. Bazel:Birkhäuser, 1969:1-10.
7. Himpe D, Van Cauwelaert P, Neels H et al. Priming solutions for cardiopulmonary bypass: comparison of three colloids. J Cardiothorac Vasc Anesth 1991;5:457-466.
8. Hoeft A, Korb H, Mehlhorn U, Stephan H, Sonntag H. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth 1991;66:73-80.
9. Ingerman-Wojenski C, Smith JB, Silver MJ. Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets. J Lab Clin Med 1983;101:44-52.
10. Kirklin JK, Lell WA, Kouchoukos NT. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization. Ann Thorac Surg 1984;37:40-46.
11. Kratzer MAA, Born GVR. Simulation of primary haemostasis in vitro. Haemostasis 1985;15:357-362.
12. Kuitunen A, Hynynen M, Salmenperä M et al. Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anesthesiol Scand 1993;37:652-658.
13. Lee WH, Rubin JW, Huggins MP. Clinical evaluation of priming solutions for pump oxygenator perfusion. Ann Thorac Surg 1975;19:529-536.
14. London MJ, Franks M, Verrier ED, Merrick SH, Levin J, Mangano DT. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. J Thorac Cardiovasc Surg 1992;104:284-296.
15. London MJ, Ho JS, Triedman JK, et al. A randomised clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989;97: 785-797.
16. Lundsgaard-Hansen P, Tschirren B. Clinical experience with 120 000 units of modified fluid gelatin. Dev Biol Stand 1981;48:251-256.
17. McGrath LB, Gonzalez-Lavin L, Neary MJ. Comparison of dextran 40 with albumin and Ringer's lactate as components of perfusion prime for cardiopulmonary bypass in patients undergoing myocardial revascularization. Perfusion 1989;4:41-49.
18. Palanzo DA, Parr GVS, Bull AP, Williams DP, O'Neill MJ, Waldhausen JA. Hetastarch as a prime for cardiopulmonary bypass. Ann Thorac Surg 1982;34:680-683.
19. Sade RM, Crawford FA, Dearing JP, Stroud M. Hydroxyethyl starch in priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1982;84:35-38.
20. Schaldach M. New aspects of biomaterial research for extracorporeal circulation. In: Hagl S, Klövekorn WP, Mayr N, Sebening F, editors. Thirty years of extracorporeal circulation. Proc Munich April 1984: Klinik fur Herz- und Gefasschirurgie, Deutsches Herzzentrum München 1984:407-418.
21. Strauss RG, Stump DC, Henriksen A, Saunders R. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 1985;25:230-234.
22. Stump DC, Strauss RG, Henriksen A, Petersen RE, Saunders R. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985;25:349-354.
23. Tabuchi N, De Haan J, Gallandat Huet RCG, Boonstra PW, van Oeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 1995;74:1447-1451.
24. Tabuchi N, De Haan J, Van Oeveren W. Rapid recovery of platelet function after cardiopulmonary bypass. Blood 1993;82:2930-2931.
25. Tigchelaar I, Monnink SHJ, Haan J, Tabuchi N, van Oeveren W. Platelet function analysis after in vitro treatment with hemostasis affecting components. Semin Thromb Hemost 1995;21(2):71-76.